Latest News and Press Releases

Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test

ImCheck to Present New Positive Data on ICT01 Monotherapyin Hematological Cancers at ESMO 2023 Interim data from Phase I dose escalation portion of EVICTION Phase I/IIa trialshow strong safety...

Revolution Medicines reports encouraging clinical data for both RMC-6236 and RMC-6291, two pioneering RAS(ON) Inhibitors, at 2023 Triple Meeting

– Expanded benchmarking of IMM-1-104 as a single agent across more than 190 patient-aligned models in humanized 3D-tumor growth assays demonstrated high sensitivity in a wide range of MAPK-driven...

Wilmington, Delaware, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Global Metastatic Colorectal Cancer Therapeutics Market is estimated at a market value of US$ 5.9 billion in 2023 and is predicted to rise at...

Un jalon pour le principal conjugué peptide-médicament de la Société après l’acceptation par la FDA, le 2 juin 2023, de la modification du protocole de l’étude de phase 1. MONTRÉAL, 12 oct....

Milestone for Company’s lead peptide-drug conjugate candidate follows FDA acceptance of protocol amendment for Phase 1 study on June 2, 2023 MONTREAL, Oct. 12, 2023 (GLOBE NEWSWIRE) --...

Findings confirm unique dual mechanism of action and fast-to-market target indication for potentially registrational trial All CICILIA trial endpoints met, with CyPep-1 demonstrating consistent...

Planatome announced its completed spinout and is now a fully separate entity. In addition, it has expanded its leadership team with two executive hires.

HELSINKI, Finland, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces it is the first biotech company in Europe...